Showing 1 - 3 results of 3, query time: 0.06s Refine Results
  1. 1
    Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial

    Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

    Published 2010
    Conference item
  2. 2
    Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial

    Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL) Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

    Published 2010
    Conference item
  3. 3
    Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial

    Inability to Tolerate Standard Therapy Is a Major Reason for Poor Outcome In Older Adults with Acute Lymphoblastic Leukemia (ALL): Results From the International MRC/ECOG Trial by Sive, J, Buck, G, Fielding, A, Lazarus, H, Litzow, MR, Luger, S, Marks, D, McMillan, A, Richards, S, Rowe, J, Tallman, MS, Goldstone, A

    Published 2010
    Conference item

Search Tools: